Nutrition - Western Pacific region's malnutrition is a double-edged sword
The WHO claims that there is a "double burden of malnutrition" prevalent in the Western Pacific region, being the "coexi...
India should walk the talk on the Covid vaccines and intellectual property rights (IPRs), after having raised the demand, along with South Africa, that members of the World Trade Organisation waive all IPR on copyright, industrial design, patents and undisclosed information, in relation to vaccines and medication for Covid-19. Even as rich countries have looked inward, India has supplied Covid vaccines as grant assistance and exports, even as it meets its huge domestic requirements. India exports indigenously developed Covaxin, besides the AstraZeneca vaccine produced by Serum Institute of India.The government should buy out the IPRs to Covaxin from its developers Bharat Biotech and ICMR, and let Bharat Biotech sell the vaccine at a price minus the component attributable to IPR, as well as license producers anywhere in the world to manufacture the vaccine, subject to quality control. The move should come ahead of this week’s meeting at the WTO on the proposal submitted by India and South Africa and backed by 57 developing countries at the last count. The waiver, to be renewed annually, would last for a specific time period agreed by the General Council, until vaccination is in place globally and the majority of the world’s population is immune. The alternative to an IPR waiver is for countries to issue compulsory licences. It is viable, but is complex and time-consuming. A waiver of IPR would be superior, by far. China is making its vaccines available devoid of IPR. That would have been a truly remarkable display of soft power, if only the vaccines available from China were all effective.If the world is to truly recover from the pandemic, it cannot do so by leaving the poorer countries behind. IPR-free vaccines would help.
View SourceThis notice has been removed
The content is no longer available
India should walk the talk on the Covid vaccines and intellectual property rights (IPRs), after having raised the demand, along with South Africa, that members of the World Trade Organisation waive all IPR on copyright, industrial design, patents and undisclosed information, in relation to vaccines and medication for Covid-19. Even as rich countries have looked inward, India has supplied Covid vaccines as grant assistance and exports, even as it meets its huge domestic requirements. India exports indigenously developed Covaxin, besides the AstraZeneca vaccine produced by Serum Institute of India.The government should buy out the IPRs to Covaxin from its developers Bharat Biotech and ICMR, and let Bharat Biotech sell the vaccine at a price minus the component attributable to IPR, as well as license producers anywhere in the world to manufacture the vaccine, subject to quality control. The move should come ahead of this week’s meeting at the WTO on the proposal submitted by India and South Africa and backed by 57 developing countries at the last count. The waiver, to be renewed annually, would last for a specific time period agreed by the General Council, until vaccination is in place globally and the majority of the world’s population is immune. The alternative to an IPR waiver is for countries to issue compulsory licences. It is viable, but is complex and time-consuming. A waiver of IPR would be superior, by far. China is making its vaccines available devoid of IPR. That would have been a truly remarkable display of soft power, if only the vaccines available from China were all effective.If the world is to truly recover from the pandemic, it cannot do so by leaving the poorer countries behind. IPR-free vaccines would help.
No results found
Try a different search term
Something went wrong
No notices yet
No notices match these filters
Couldn't load notices
You're all caught up 🎉
Sign in to continue to Global Noticeboard
Enter your email to receive a reset link
Create a new password for your account
You are marking this Notice are inappropriate, and you belive it infringes on the Global Noticeboard Community Guidelines (link). Is this so?
Create 3 Noticeboards to earn this Silver level Community Champion Badge.
View all badges that you can earnPlease tell us why you are reporting this content.
Discussion (0)
No comments yet